Tesamorelin

Tesamorelin

Tesamorelin, (formerly known as TH9507), is a type of peptide called a growth hormone-releasing factor (GHRF). GHRF causes growth hormone to be created and spread in the body, which helps increase metabolism, reduce belly fat, improve body shape, and use of energy.

Product Details

Human Growgh Peptide Tesamorelin Egrifta for Bodybuilding

Foshan Xinhang Biological Technology Co., Ltd.

Whatsapp:+8617725670492, email:liuxf@yccreate.com.

Key words:Tesamorelin ,Egrifta,Human Growgh Peptide,


1.Product Introduction

Welcome to contact Morgan for more details.Whatsapp:+8617725670492, email:liuxf@yccreate.com.

Tesamorelin, (formerly known as TH9507), is a type of peptide called a growth hormone-releasing factor (GHRF). GHRF causes growth hormone to be created and spread in the body, which helps increase metabolism, reduce belly fat, improve body shape, and use of energy. Tesamorelin (formerly known as TH9507) is a synthetic growth hormone-releasing factor that stimulates the pituitary gland in the brain to secrete growth hormone; this indirect approach appears to maintain more stable, natural levels, like CJC-1295 DAC,. Clinical trials have shown that tesamorelin significantly reduces abdominal fat with fewer side effects than human growth hormone itself, although abdominal fat may return after the Tesamorlein is discontinued (depending upon the individual). Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals as well as similarly reducing abdominal fat in NON-HIV-Infected individuals.


2.Specifications:

Tesamorelin effectively breaks down fat accumulated in the waist and the abdominal cavity, and prevents re-accumulation

· Tesamorelin excellent streamlines the metabolism, transport of nutrients and energy in the body

· Tesamorelin is the best drug for metabolic diseases and disorders,

· Tesamorelin improves memory and ability to learn, supports brain function

· Tesamorelin causes an improvement in mental alertness and activity, and cognitive abilities (eg. The results achieved in vocational training)

· Tesamorelin heals and strengthens the nervous system


3.Applications:

The daily 2-mg dose of EGRIFTA® is reconstituted from 2 vials of drug, each containing 1 mg of tesamorelin acetate and 100 mg of mannitol as a lyophilized powder

The total injection volume is 2 mL
Sterile Water for Injection (USP) for reconstitution is provided in a separate bottle
Once reconstituted, EGRIFTA® must be administered immediately
Non-reconstituted EGRIFTA® must be stored at refrigerated temperature, between 2°C and 8°C (36°F and 46°F) until dispensed. Upon dispensing, the patient must store non-reconstituted EGRIFTA® at refrigerated temperature until the expiration date. The reconstitution diluent (Sterile Water for Injection, USP), syringes and needles should be stored at controlled room temperature of 20ºC to 25ºC (68°F to 77°F).
Patients should be directed to the Patient Instructions for Use for further information regarding reconstitution

Tesamorelin


4. prodection details

Product Name

Egrifta (Tesamorelin)

Molecular Formula

C223H370N72O69S

Molecular Weight

5195.908 g/mol

Specification

2mg/vial, 10vials/kit

Package

Glass vials, perfect discreet, as required

Minimum Order

One Kit (10vials)

Delivery Time

4-7 Business Days Door to Door

Custom Passrate

Guaranteed


5.Product Qualification

Fat Loss and the Tesamorelin Peptide

Tesamorelin has been shown to reduce lipodystrophy in HIV-infected individuals. Lipodystrophy is a condition that causes changes in placement of body fat, including wasting and fat accumulation, and changes in metabolism. Similar to Tesamorelin is Sermorelin, which may be taken with GHRP-6 is clinical trials, that also promotes HGH production and possible fat loss. Individuals with lipodystrophy may develop excess fat most notably around the liver, stomach, and other abdominal organs (visceral body fat).

Tesamorelin is an analogue of GHRH (growth hormone releasing hormone, a naturally-occurring peptide released from the hypothalamus) that was recently approved by the FDA for treatment (reduction) of HIV-induced lipodystrophy-related visceral fat and is now marketed under the trade name Egrifta. Like GHRH, tesamorelin exerts its effects through inducing GH release from the pituitary.

Tesamorelin has a wide variability of pharmacokinetics among individuals. The recommended and best-studied dose is 2mg dosed weekly or daily. It has been demonstrated to have low oral bioavailability and is dosed subcutaneously.[1]

Lipodystrophy is the medical term for a condition characterized by the abnormal condition of fat deposits, specifically lipoatrophy in most cases. In HIV-induced lipodostrophy sometimes normal fat deposits, such as those that give the face its shape, shrink and atrophy while others can grow and pose a risk to patient health. One such example of unhealthy fat deposits is visceral adipose tissue.


6.Delivery,shipping and serving

Shipping

By Express

By Air

By Sea

Suitable for under 50kg

Fast: 3-7 days

High cost

Door to door service,

easy to pick up the goods

Suitable for more than 50kg

Fast: 3-7 days

High cost

Port to port,

professional broker needed

Suitable for more than 500kg

Slow: 7-45 days

Low cost

Port to port,

professional broker needed


7.FAQ
1. Any inquiries will be replied within 12 hours.
2. Dedication to quality, supply & service.
3. Strictly on selecting raw materials.
4. OEM/ODM Available.
5. Reasonable & competitive price, fast lead time.
6. Sample is available for your evaluation & Formulation development.
7. Faster delivery:
Sample order in stock and 3-7 days for bulk production.
8. We have strong cooperation with DHL, TNT, UPS, FEDEX, EMS. Or you also can choose your own shipping forwarder.
9. After-Sale Service:
(1) International Authorized Third-Party Test For The Products You Demand.
(2) 60 Days Warranty of quality of goods

Hot Tags: tesamorelin, China, manufacturers, suppliers, factory, wholesale

Inquiry

You Might Also Like